This paper aims to describe the clinical test of a Telepalliation program, a digital platform for patients in palliation and their relatives. The paper describes the research design, outcome measures and techniques used for data collection.
The Telepalliation program will be conducted as a randomized controlled study. The intervention group will follow the Telepalliation program, while the control group will follow the traditional standard of care program for palliative care. The primary outcome of the study is increased quality of life, measured by EORTC QLQ-C15-PAL. Secondary outcomes include the enhanced sense of security; reduced experience of pain; satisfactory experiences of both patients and relatives on the use of TelePal.dk platform and degree of satisfaction in being a part of a Telepalliation program; experiences with the actual use of the TelePal.dk platform from healthcare professionals and the professionals’ experiences of being a part of a telepalliation program; the usability of a cross-sector communication platform and telepalliation program by patients, relatives, and health care professionals; and the projected lower cost of healthcare services, in terms of quantity of phone/video calls, equipment, etc. These outcomes will be assessed using questionnaires, through data generated by digital technologies and through semi-structured interviews.
Collection of data began in May 2021 and will be completed in June 2024. The results of the study will be published in peer-reviewed journals and presented at international conferences. Results from the Telepalliation program are expected to be published by fall 2024.
The expected outcomes of the study are increased quality of life and increased sense of security. We also expect that the study will have a clinical impact for future telepalliative care for those patients who are referred to a Palliative Team. Clinical Trial: NCT04995848 and N-202000094